Company Filing History:
Years Active: 2022-2025
Title: Natalie Fosh: Innovator in Cancer Therapy
Introduction
Natalie Fosh is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of cancer therapy through her innovative work. With a total of 3 patents, her inventions focus on specific binding members that target lymphocyte-activation gene 3 (LAG-3).
Latest Patents
Her latest patents include advancements in LAG-3 binding members. The present invention relates to specific binding members which bind to lymphocyte-activation gene 3 (LAG-3). These specific binding members preferably comprise a LAG-3 antigen-binding site, which may be located in two or more structural loops of a CH3 domain of the specific binding member. The specific binding members of the invention find application, for example, in cancer therapy.
Career Highlights
Throughout her career, Natalie has worked with notable companies such as F-star Therapeutics, Inc. and Invox Pharma Limited. Her work in these organizations has furthered her research and development in the field of biotechnology.
Collaborations
Some of her coworkers include Mihriban Tuna and Francisca Wollerton Van Horck. Their collaborative efforts have contributed to the success of her projects and innovations.
Conclusion
Natalie Fosh is a key figure in the development of innovative solutions for cancer therapy. Her work continues to impact the field positively, showcasing her dedication to advancing medical science.